Improving Patients’ Lives with Low-Dose Naltrexone
LDN
•
56m
Download Handout:
Run Time: 57 minutes
Approximately 50 million Americans, 20 percent of the population, suffer from autoimmune diseases and more than 100 autoimmune disorders have been identified to date. The good news? Low-dose naltrexone (LDN) has been studied recently regarding its application for autoimmune disorders. Sebastian will provide insight into the science, physiology and mechanisms of action of LDN, as well as the many conditions it may be beneficial for.
Up Next in LDN
-
How Pharmacists Can Partner with Prac...
During this presentation, Dr. Sarah Zielsdorf, MD, MS will share how pharmacists can partner with their practitioners to expand awareness of LDN.
-
Back to Basics: Understanding the Imm...
Run time: 1 hour 7 minutes
Download handout: https://bit.ly/3V307xNDuring this presentation, PCCA’s Clinical Compounding Pharmacist, Sebastian Denison will share basics about understanding the immune system and autoimmune disorders. After watching this presentation, the viewer should be able to...
-
LDN Compounding Opportunities: Post-C...
Run time: 2 hour 15 minutes
Download handout: https://bit.ly/3P7ZGhYThis compilation of four presentations from PCCA’s Clinical Compounding Pharmacists will feature presentations covering formulas to help with symptoms related to Parkinson’s Disease, Multiple Sclerosis, ALS, Hashimoto’s and Lup...
